I appreciate those comments, but we also heard from a professor earlier today from the University of Windsor, who said that the analysis has to be on what happens to Canada if the other partners are in the TPP and we're not. He seemed to conclude that the impact on the auto sector would be far more devastating if we weren't at the table and the U.S. and Japan and other countries were. Again, it's a balancing act and an analysis that we have to do.
Natalie, I want to talk to you about pharmacy. You mentioned that Canada is already the second-most expensive OECD country to buy drugs in, second only to the U.S. That is an issue, but what does it have to do with the TPP? Is it a bigger problem that can be addressed outside of any form of framework like the TPP? Are there other things we can be doing that have nothing to do with international trade whatsoever, or extension of copyright, or things like that? Are there other steps we should be taking and looking at that, if we do ratify the deal, may mitigate that factor?